Am I Eligible for the Test?

The Oncotype DX® breast cancer test is a diagnostic test performed after your original breast cancer surgery. Like other laboratory tests, it must be ordered by an authorised healthcare provider (i.e. your breast cancer surgeon or oncologist). You may use the checklist below to help determine if you are a potential candidate for the Oncotype DX breast cancer test

You may be a candidate for the Oncotype DX breast cancer test if you are medically eligible for chemotherapy and:

  • You have been recently diagnosed with anatomic stage I,II or IIIa invasive breast cancer.
  • Your breast cancer is estrogen-receptor positive (ER+) 
  • Human Epidermal growth factor Receptor-negative (HER2-)

If you are uncertain whether or not you are a candidate for the Oncotype DX breast cancer test, please ask your doctor*. Genomic Health is not able to advise you directly on your treatment plan.

The decision whether or not to order the Oncotype DX breast cancer test is one that you and your doctor should make together.

*Breast surgeon or oncologist

Making cancer care smarter.™

This site uses cookies. These cookies collect information about how visitors use a website, for instance which pages visitors go to most often, and if they get error messages from web pages. These cookies don’t collect information that identifies a visitor. All information these cookies collect is used only to improve the website. By visiting this website, you agree that we can place these types of cookies on your device.